| Amandeep Kaur Nagra, MD, MPH | |
|
301 Sullivan Way, Trenton Psychiatric Hospital, West Trenton, NJ 08628 | |
| (609) 633-1500 | |
| Not Available |
| Full Name | Amandeep Kaur Nagra |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 301 Sullivan Way, West Trenton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225292196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA08330600 (New Jersey) | Primary |
| Entity Name | State Of New Jersey Omb Centralized Payroll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467552240 PECOS PAC ID: 6406742592 Enrollment ID: O20050603000317 |
News Archive
Viragen, Inc today reported on the progression of anti-viral studies using Multiferon (multi-subtype, natural human alpha interferon) being conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).
The U.S. Food and Drug Administration today announced draft guidance that would expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual's participation at an FDA advisory committee meeting.
The Wall Street Journal: "The Food and Drug Administration said it is weighing whether to seek criminal penalties against the Johnson & Johnson unit that made children's Tylenol and other over-the-counter kids' medicines recalled last month. Joshua Sharfstein, the FDA's principal deputy commissioner, told lawmakers at a hearing Thursday that J&J's McNeil Consumer Healthcare unit had a 'pattern of noncompliance' with good manufacturing practices.
A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amandeep Kaur Nagra, MD, MPH 301 Sullivan Way, Trenton Psychiatric Hospital, West Trenton, NJ 08628 Ph: (609) 633-1500 | Amandeep Kaur Nagra, MD, MPH 301 Sullivan Way, Trenton Psychiatric Hospital, West Trenton, NJ 08628 Ph: (609) 633-1500 |
News Archive
Viragen, Inc today reported on the progression of anti-viral studies using Multiferon (multi-subtype, natural human alpha interferon) being conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).
The U.S. Food and Drug Administration today announced draft guidance that would expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual's participation at an FDA advisory committee meeting.
The Wall Street Journal: "The Food and Drug Administration said it is weighing whether to seek criminal penalties against the Johnson & Johnson unit that made children's Tylenol and other over-the-counter kids' medicines recalled last month. Joshua Sharfstein, the FDA's principal deputy commissioner, told lawmakers at a hearing Thursday that J&J's McNeil Consumer Healthcare unit had a 'pattern of noncompliance' with good manufacturing practices.
A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
› Verified 4 days ago
Yoonhee Han, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 301 Sullivan Way, West Trenton, NJ 08628 Phone: 609-633-1562 Fax: 609-633-8527 | |
Yves Georges Dubois, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 Sullivan Way, West Trenton, NJ 08628 Phone: 609-633-1562 Fax: 609-633-8527 | |
Dr. Elizabeth Anne Hogan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7717 Stuyvesant Ave, Ann Klein Forensic Center, West Trenton, NJ 08628 Phone: 609-633-0916 Fax: 609-633-1030 | |
Suhas Shanbhag, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Sullivan Way, Trenton Psychiatric Hospital, West Trenton, NJ 08628 Phone: 609-633-1502 | |
Dr. Uma S Joshi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Sullivan Way, West Trenton, NJ 08628 Phone: 609-633-1562 Fax: 609-633-8527 | |
Dr. Aida Rodrigo Nunez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 301 Sullivan Way, West Trenton, NJ 08628 Phone: 609-633-1562 |